Retatrutide – 60 MG

Retatrutide – 60MG is a high-dose research peptide designed for advanced, long-duration metabolic studies. As a triple agonist of GLP-1, GIP, and glucagon receptors, it is one of the most innovative compounds in the study of obesity, fat loss, insulin sensitivity, and energy balance.

With a 60MG strength, this vial supports up to 6–12 weeks of continuous research, minimising the need for multiple vials or reorders. Ideal for laboratories conducting dose-dependent response testing, extended animal studies, or high-volume peptide blending.

Research Benefits:

• Triple Pathway Activation:
  Enhances insulin secretion, suppresses appetite, and promotes fat oxidation simultaneously.

• Extreme Weight Reduction Potential:
  Clinical trials have shown Retatrutide to outperform both Semaglutide and Tirzepatide, achieving 24%+ body weight loss.

• Improves Glycaemic Control:
  Significantly lowers HbA1c and fasting glucose levels in diabetic research models.

• Boosts Energy Expenditure:
  Supports mitochondrial health and increases basal metabolic rate.

Reconstitution Guidelines:

• Reconstitute with 3ml–6ml of Bacteriostatic Water for Injection (BWFI), depending on concentration preference.

• Store reconstituted solution at 2–8°C (refrigerated).

• Use within 30 days of reconstitution for best stability.

Why Choose Retatrutide – 60MG?

• Extended Research Window – Fewer vials needed for 6+ week protocols

• Exceptional Value – Cost-effective per mg for bulk research

• Ultra-Pure Quality – Lab-tested, >99% purity with verified COA

• Compatible with Blending – Ideal for multi-compound weight loss stacks

⚠️ For Research Use Only
This product is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption or veterinary use. Sold strictly for laboratory research and development purposes.